tyvense 30 mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - psychoanaleptics
tyvense 40mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - centrally acting sympathomimetics
tyvense 50 mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - psychoanaleptics
tyvense 60mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - centrally acting sympathomimetics
tyvense 70 mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - psychoanaleptics
tonpular xl 150 mg prolonged-release hard capsules
wockhardt uk limited - venlafaxine - prolonged-release capsule, hard - 150 milligram(s) - other antidepressants; venlafaxine
tonpular xl 75 mg prolonged-release hard capsules
wockhardt uk limited - venlafaxine - prolonged-release capsule, hard - 75 milligram(s) - other antidepressants; venlafaxine
apo-amoxycillin amoxicillin (as trihydrate) 250 mg capsules blister pack
arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 286.96 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium lauryl sulfate; gelatin; croscarmellose sodium; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see section 5.1 pharmacodynamic properties - microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
apo-amoxycillin amoxicillin (as trihydrate) 500 mg capsules blister pack
arrotex pharmaceuticals pty ltd - amoxicillin trihydrate, quantity: 573.921 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; titanium dioxide; colloidal anhydrous silica; sodium lauryl sulfate; gelatin; croscarmellose sodium; iron oxide black; microcrystalline cellulose; iron oxide red; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see section 5.1 pharmacodynamic properties - microbiology). respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli (see section 5.1 pharmacodynamic properties - microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see section 5.1 pharmacodynamic properties - microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
tyvense 20mg capsules, hard
shire pharmaceuticals ireland limited - lisdexamfetamine dimesylate - capsule, hard - 20 milligram(s) - centrally acting sympathomimetics